Related Experiment Video
Updated: Dec 2, 2025

03:55
Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
Published on: June 9, 2023
810
Prophylactic central node dissection in differentiated thyroid cancer: A prospective tertiary care center experience
Associate Professor And Senior Advisor Dr Debashish Mukherjee1, Senior Resident Dr Amiy Arnav1, Senior Resident Dr Varun Kumar Agarwal1
1Army Hospital Research And Refferal, Delhi Cantt, 110010 India.
Cancer Treatment and Research Communications
|November 1, 2020
Summary
Prophylactic central neck dissection in differentiated thyroid cancer is associated with minimal morbidity and aids in accurate staging, particularly for high-risk patients. This procedure helps identify nodal metastases, improving patient management and reducing recurrence risk.
Area of Science:
- Oncology
- Surgical Pathology
- Endocrinology
Background:
- Central lymph node metastasis is the most common recurrence site in differentiated thyroid cancer.
- Optimal management of these nodes remains a clinical challenge.
- Prophylactic central neck dissection (PCND) aims to address this by evaluating nodal status and reducing recurrence.
Purpose of the Study:
- To assess the morbidity associated with PCND in differentiated thyroid cancer.
- To correlate histopathological features of the primary tumor with central lymph node metastasis.
- To evaluate the role of PCND in accurate cancer staging.
Main Methods:
- A prospective, observational study of 30 patients with differentiated thyroid cancer and no prior neck surgery.
- All patients underwent total thyroidectomy with bilateral PCND.
- Surgical outcomes (hypoparathyroidism, nerve palsy) and histopathological findings were analyzed.
Main Results:
- Classical histology, tumor size >4 cm, lymphovascular invasion, and multifocality were significantly linked to increased central lymph node metastasis.
- Transient and permanent hypoparathyroidism occurred in 36.3% and 10% of patients, respectively.
- PCND led to upstaging in 35% of pT1 or T2 lesions, aiding in postoperative treatment planning.
Conclusions:
- PCND can be performed with minimal morbidity at high-volume centers.
- It plays a crucial role in accurate staging for specific patient groups (male, age >45, large tumors, etc.).
- PCND improves risk stratification and guides postoperative management for differentiated thyroid cancer.

